Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Merit Medical Systems, Inc.
If you are a shareholder who suffered a loss, click here to participate.
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact
On
On this news, the Company’s stock price fell
On
On this news, the Company’s stock price fell
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (2) that sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased Merit common stock during the Class Period, you may move the Court no later than
This press release may be considered
View source version on businesswire.com: https://www.businesswire.com/news/home/20191210005051/en/
[email protected]
www.glancylaw.com
Source:
Wink Unveils Beefed Up AnnuitySpecs Tool
Is It Possible To Get Affordable Car Insurance Rates When The Spouse Was Convicted For DUI/ DWI?
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News